Drugs and sexual desire (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Drugs and sexual desire" in English language version.

Last modified: 12:08:20, 3 March 2026 (UTC)

Ref.Un. Ref.Website

Global rank English rank

10944nih.gov

5^th place

9033doi.org

2^nd place

7327worldcat.org

4^th place

268semanticscholar.org

15^th place

8^th place

156fda.gov

470^th place

329^th place

155elsevier.com

365^th place

372^nd place

145web.archive.org

1^st place

92springer.com

182^nd place

172^nd place

72sagepub.com

609^th place

451^st place

51medicines.org.uk

4,892^nd place

3,451^st place

42tandfonline.com

286^th place

209^th place

31hdl.handle.net

66^th place

34^th place

21jsexmed.org

low place

21oup.com

292^nd place

233^rd place

11issm.info

low place

doi.org (Global: 2^nd place; English: 2^nd place)

doi.org

Stahl, Stephen M. (2015-02-09). "Mechanism of action of flibanserin, a multifunctional serotonin agonist and antagonist (MSAA), in hypoactive sexual desire disorder". CNS Spectrums. 20 (1): 1–6. doi:10.1017/S1092852914000832. ISSN 1092-8529. PMID 25659981.
Pfaus, James (May 2017). "Brain Mechanisms of Sexual Desire, Pleasure, And Inhibition". The Journal of Sexual Medicine. 14 (5): e211. doi:10.1016/j.jsxm.2017.05.009.
Mayer, Danielle; Lynch, Sarah E. (2020-07-01). "Bremelanotide: New Drug Approved for Treating Hypoactive Sexual Desire Disorder". Annals of Pharmacotherapy. 54 (7): 684–690. doi:10.1177/1060028019899152. ISSN 1060-0280. PMID 31893927. S2CID 209539372.
DeRogatis, Leonard; Rosen, Raymond C.; Goldstein, Irwin; Werneburg, Brian; Kempthorne-Rawson, Joan; Sand, Michael (March 2012). "Characterization of Hypoactive Sexual Desire Disorder (HSDD) in Men". The Journal of Sexual Medicine. 9 (3): 812–820. doi:10.1111/j.1743-6109.2011.02592.x. PMID 22239825.
Turner, Daniel; Briken, Peer (January 2018). "Treatment of Paraphilic Disorders in Sexual Offenders or Men With a Risk of Sexual Offending With Luteinizing Hormone-Releasing Hormone Agonists: An Updated Systematic Review". The Journal of Sexual Medicine. 15 (1): 77–93. doi:10.1016/j.jsxm.2017.11.013. ISSN 1743-6109. PMID 29289377.
Bloemers, Jos; van Rooij, Kim; Poels, Saskia; Goldstein, Irwin; Everaerd, Walter; Koppeschaar, Hans; Chivers, Meredith; Gerritsen, Jeroen; van Ham, Diana; Olivier, Berend; Tuiten, Adriaan (March 2013). "Toward Personalized Sexual Medicine (Part 1): Integrating the "Dual Control Model" into Differential Drug Treatments for Hypoactive Sexual Desire Disorder and Female Sexual Arousal Disorder". The Journal of Sexual Medicine. 10 (3): 791–809. doi:10.1111/j.1743-6109.2012.02984.x. PMID 23130782.
Tuiten, Adriaan; van Rooij, Kim; Bloemers, Jos; Eisenegger, Christoph; van Honk, Jack; Kessels, Rob; Kingsberg, Sheryl; Derogatis, Leonard R.; de Leede, Leo; Gerritsen, Jeroen; Koppeschaar, Hans P.F. (February 2018). "Efficacy and Safety of On-Demand Use of 2 Treatments Designed for Different Etiologies of Female Sexual Interest/Arousal Disorder: 3 Randomized Clinical Trials". The Journal of Sexual Medicine. 15 (2): 201–216. doi:10.1016/j.jsxm.2017.11.226. hdl:11370/759c7d86-e8d6-4629-8f60-3b6eea650d5f. PMID 29289554.
Tuiten, Adriaan; Michiels, Frits; Böcker, Koen BE; Höhle, Daniël; van Honk, Jack; de Lange, Robert PJ; van Rooij, Kim; Kessels, Rob; Bloemers, Jos; Gerritsen, Jeroen; Janssen, Paddy (2018-01-01). "Genotype scores predict drug efficacy in subtypes of female sexual interest/arousal disorder: A double-blind, randomized, placebo-controlled cross-over trial". Women's Health. 14: 174550651878897. doi:10.1177/1745506518788970. ISSN 1745-5065. PMC 6052493. PMID 30016917.
van Rooij, Kim; Poels, Saskia; Bloemers, Jos; Goldstein, Irwin; Gerritsen, Jeroen; van Ham, Diana; van Mameren, Frederiek; Chivers, Meredith; Everaerd, Walter; Koppeschaar, Hans; Olivier, Berend (March 2013). "Toward Personalized Sexual Medicine (Part 3): Testosterone Combined with a Serotonin1A Receptor Agonist Increases Sexual Satisfaction in Women with HSDD and FSAD, and Dysfunctional Activation of Sexual Inhibitory Mechanisms". The Journal of Sexual Medicine. 10 (3): 824–837. doi:10.1111/j.1743-6109.2012.02982.x. PMID 23130675.
Aftab, Awais; Chen, Cheryl; McBride, Jacob (April 2017). "Flibanserin and its discontents". Archives of Women's Mental Health. 20 (2): 243–247. doi:10.1007/s00737-016-0693-6. ISSN 1434-1816. PMID 27858170. S2CID 4534394.
Phillips, Elizabeth A.; Rajender, Archana; Douglas, Thomas; Brandon, Ashley F.; Munarriz, Ricardo (2015-07-01). "Sex Offenders Seeking Treatment for Sexual Dysfunction—Ethics, Medicine, and the Law". The Journal of Sexual Medicine. 12 (7): 1591–1600. doi:10.1111/jsm.12920. ISSN 1743-6095. PMC 6962056. PMID 26060942.
Vallejos, Ximena; Wu, Christine (2017-04-01). "Flibanserin: A Novel, Nonhormonal Agent for the Treatment of Hypoactive Sexual Desire Disorder in Premenopausal Women". Journal of Pharmacy Practice. 30 (2): 256–260. doi:10.1177/0897190016630409. ISSN 0897-1900. PMID 26873507. S2CID 196435523.
Thompson, Cheryl A. (2015-10-01). "Onsite pharmacist program in medical homes declared a success". American Journal of Health-System Pharmacy. 72 (19): 1596–1597. doi:10.2146/news150064. ISSN 1079-2082. PMID 26386093.
Pfaus, James G. (2015-10-22). "Treatment for Hypoactive Sexual Desire". Cell. 163 (3): 533. doi:10.1016/j.cell.2015.10.015. PMID 26496594.
Shapiro, Desiree; Stevens, Deanna; Stahl, Stephen M. (2017-10-02). "Flibanserin – the female Viagra?". International Journal of Psychiatry in Clinical Practice. 21 (4): 259–265. doi:10.1080/13651501.2017.1315138. ISSN 1365-1501. PMID 28434386. S2CID 40960102.
Puppo, Giulia; Puppo, Vincenzo (2016-02-24). "US Food and Drug Administration Approval of Addyi (Flibanserin) for Treatment of Hypoactive Sexual Desire Disorder". European Urology. 69 (2): 379–380. doi:10.1016/j.eururo.2015.09.050. PMID 26455357.
Jaspers, Loes; Feys, Frederik; Bramer, Wichor M.; Franco, Oscar H.; Leusink, Peter; Laan, Ellen T. M. (2016-04-01). "Efficacy and Safety of Flibanserin for the Treatment of Hypoactive Sexual Desire Disorder in Women: A Systematic Review and Meta-analysis". JAMA Internal Medicine. 176 (4): 453–462. doi:10.1001/jamainternmed.2015.8565. ISSN 2168-6106. PMID 26927498.
Joffe, Hylton V.; Chang, Christina; Sewell, Catherine; Easley, Olivia; Nguyen, Christine; Dunn, Somya; Lehrfeld, Kimberly; Lee, LaiMing; Kim, Myong-Jin; Slagle, Ashley F.; Beitz, Julie (2016-01-14). "FDA Approval of Flibanserin — Treating Hypoactive Sexual Desire Disorder". New England Journal of Medicine. 374 (2): 101–104. doi:10.1056/NEJMp1513686. ISSN 0028-4793. PMID 26649985.
Brotto, Lori A. (November 2015). "Flibanserin". Archives of Sexual Behavior. 44 (8): 2103–2105. doi:10.1007/s10508-015-0643-9. ISSN 0004-0002. PMID 26503709.
Clayton, Anita H; Brown, Louise; Kim, Noel N (2020-01-02). "Evaluation of safety for flibanserin". Expert Opinion on Drug Safety. 19 (1): 1–8. doi:10.1080/14740338.2020.1707804. ISSN 1474-0338. PMID 31855607. S2CID 209427946.
Dhillon, Sohita; Keam, Susan J. (September 2019). "Bremelanotide: First Approval". Drugs. 79 (14): 1599–1606. doi:10.1007/s40265-019-01187-w. ISSN 0012-6667. PMID 31429064. S2CID 201057982.
Aschenbrenner, Diane S. (October 2019). "New Drug for Hypoactive Sexual Desire Disorder in Premenopausal Women". American Journal of Nursing. 119 (10): 21. doi:10.1097/01.NAJ.0000586140.72896.b0. ISSN 0002-936X. PMID 31567244. S2CID 203625416.
Simon, James A.; Kingsberg, Sheryl A.; Portman, David; Williams, Laura A.; Krop, Julie; Jordan, Robert; Lucas, Johna; Clayton, Anita H. (November 2019). "Long-Term Safety and Efficacy of Bremelanotide for Hypoactive Sexual Desire Disorder". Obstetrics & Gynecology. 134 (5): 909–917. doi:10.1097/AOG.0000000000003514. ISSN 0029-7844. PMC 6819023. PMID 31599847.
Mayer, Danielle; Lynch, Sarah E. (2020-07-01). "Bremelanotide: New Drug Approved for Treating Hypoactive Sexual Desire Disorder". Annals of Pharmacotherapy. 54 (7): 684–690. doi:10.1177/1060028019899152. ISSN 1060-0280. PMID 31893927. S2CID 209539372.
Huerta-Reyes, Maira; Maya-Núñez, Guadalupe; Pérez-Solis, Marco Allán; López-Muñoz, Eunice; Guillén, Nancy; Olivo-Marin, Jean-Christophe; Aguilar-Rojas, Arturo (2019-10-01). "Treatment of Breast Cancer With Gonadotropin-Releasing Hormone Analogs". Frontiers in Oncology. 9: 943. doi:10.3389/fonc.2019.00943. ISSN 2234-943X. PMC 6779786. PMID 31632902.
Meani, Davide; Solarić, Mladen; Visapää, Harri; Rosén, Rose-Marie; Janknegt, Robert; Soče, Majana (2018-02-01). "Practical differences between luteinizing hormone-releasing hormone agonists in prostate cancer: perspectives across the spectrum of care". Therapeutic Advances in Urology. 10 (2): 51–63. doi:10.1177/1756287217738985. ISSN 1756-2872. PMC 5805008. PMID 29434673.
Frank, Samuel; Tyson, Nichole A. (December 2020). "A Clinical Approach to Catamenial Epilepsy: A Review". The Permanente Journal. 24 (5): 1–3. doi:10.7812/TPP/19.145. ISSN 1552-5775. PMC 7849269. PMID 33482944.
Surgical Management of the Transgender Patient. 2016. doi:10.1016/c2016-0-00454-0. ISBN 9780323480895.
Malinowski, Bartosz; Wiciński, Michał; Musiała, Nikola; Osowska, Ilona; Szostak, Mateusz (2019-10-25). "Previous, Current, and Future Pharmacotherapy and Diagnosis of Prostate Cancer—A Comprehensive Review". Diagnostics. 9 (4): 161. doi:10.3390/diagnostics9040161. PMC 6963205. PMID 31731466.
Connelly, Paul J.; Clark, Anna; Touyz, Rhian M.; Delles, Christian (2020-11-05). "Transgender adults, gender-affirming hormone therapy and blood pressure: a systematic review". Journal of Hypertension. 39 (2): 223–230. doi:10.1097/hjh.0000000000002632. ISSN 0263-6352. PMC 7810409. PMID 32809982.
Jing, Elizabeth; Straw-Wilson, Kristyn (2016-07-01). "Sexual dysfunction in selective serotonin reuptake inhibitors (SSRIs) and potential solutions: A narrative literature review". Mental Health Clinician. 6 (4): 191–196. doi:10.9740/mhc.2016.07.191. ISSN 2168-9709. PMC 6007725. PMID 29955469.

dx.doi.org

Aschenbrenner, Diane S. (October 2019). "New Drug for Hypoactive Sexual Desire Disorder in Premenopausal Women". American Journal of Nursing. 119 (10): 21. doi:10.1097/01.NAJ.0000586140.72896.b0. ISSN 0002-936X. PMID 31567244. S2CID 203625416.
Surgical Management of the Transgender Patient. 2016. doi:10.1016/c2016-0-00454-0. ISBN 9780323480895.

elsevier.com (Global: 365^th place; English: 372^nd place)

linkinghub.elsevier.com

Pfaus, James (May 2017). "Brain Mechanisms of Sexual Desire, Pleasure, And Inhibition". The Journal of Sexual Medicine. 14 (5): e211. doi:10.1016/j.jsxm.2017.05.009.
DeRogatis, Leonard; Rosen, Raymond C.; Goldstein, Irwin; Werneburg, Brian; Kempthorne-Rawson, Joan; Sand, Michael (March 2012). "Characterization of Hypoactive Sexual Desire Disorder (HSDD) in Men". The Journal of Sexual Medicine. 9 (3): 812–820. doi:10.1111/j.1743-6109.2011.02592.x. PMID 22239825.
Bloemers, Jos; van Rooij, Kim; Poels, Saskia; Goldstein, Irwin; Everaerd, Walter; Koppeschaar, Hans; Chivers, Meredith; Gerritsen, Jeroen; van Ham, Diana; Olivier, Berend; Tuiten, Adriaan (March 2013). "Toward Personalized Sexual Medicine (Part 1): Integrating the "Dual Control Model" into Differential Drug Treatments for Hypoactive Sexual Desire Disorder and Female Sexual Arousal Disorder". The Journal of Sexual Medicine. 10 (3): 791–809. doi:10.1111/j.1743-6109.2012.02984.x. PMID 23130782.
van Rooij, Kim; Poels, Saskia; Bloemers, Jos; Goldstein, Irwin; Gerritsen, Jeroen; van Ham, Diana; van Mameren, Frederiek; Chivers, Meredith; Everaerd, Walter; Koppeschaar, Hans; Olivier, Berend (March 2013). "Toward Personalized Sexual Medicine (Part 3): Testosterone Combined with a Serotonin1A Receptor Agonist Increases Sexual Satisfaction in Women with HSDD and FSAD, and Dysfunctional Activation of Sexual Inhibitory Mechanisms". The Journal of Sexual Medicine. 10 (3): 824–837. doi:10.1111/j.1743-6109.2012.02982.x. PMID 23130675.
Puppo, Giulia; Puppo, Vincenzo (2016-02-24). "US Food and Drug Administration Approval of Addyi (Flibanserin) for Treatment of Hypoactive Sexual Desire Disorder". European Urology. 69 (2): 379–380. doi:10.1016/j.eururo.2015.09.050. PMID 26455357.

fda.gov (Global: 470^th place; English: 329^th place)

accessdata.fda.gov

The United States Food and Drug Administration, FDA (December 2025). "Addyi" (PDF). Retrieved 9 February 2026.{{cite web}}: CS1 maint: url-status (link)
The United States Food and Drug Administration, FDA (June 2019). "Vylessi" (PDF). Archived from the original (PDF) on June 22, 2019. Retrieved 15 April 2021.
The United States Food and Drug Administration, FDA (January 2012). "Synarel®" (PDF). Archived from the original (PDF) on November 6, 2015. Retrieved 2021-03-28.
The United States Food and Drug Administration, FDA (March 2012). "LUPRON DEPOT® -3 Month 11.25 mg" (PDF). Archived from the original (PDF) on January 18, 2017. Retrieved 2021-03-28.
The United States Food and Drug Administration, FDA (2008-09-13). "ZOLADEX® (goserelin acetate implant) 3.6 mg" (PDF). Archived from the original (PDF) on March 2, 2013. Retrieved 2021-03-28.
The United States Food and Drug Administration, FDA (June 2017). "TRIPTODUR (triptorelin) for extended-release injectable suspension, for intramuscular use" (PDF). Archived from the original (PDF) on October 19, 2020. Retrieved 2021-03-28.

hdl.handle.net (Global: 66^th place; English: 34^th place)

Tuiten, Adriaan; van Rooij, Kim; Bloemers, Jos; Eisenegger, Christoph; van Honk, Jack; Kessels, Rob; Kingsberg, Sheryl; Derogatis, Leonard R.; de Leede, Leo; Gerritsen, Jeroen; Koppeschaar, Hans P.F. (February 2018). "Efficacy and Safety of On-Demand Use of 2 Treatments Designed for Different Etiologies of Female Sexual Interest/Arousal Disorder: 3 Randomized Clinical Trials". The Journal of Sexual Medicine. 15 (2): 201–216. doi:10.1016/j.jsxm.2017.11.226. hdl:11370/759c7d86-e8d6-4629-8f60-3b6eea650d5f. PMID 29289554.

issm.info (Global: low place; English: low place)

"What types of drugs have general sexual side effects?". ISSM. 2014-06-02. Retrieved 2021-03-28.

jsexmed.org (Global: low place; English: low place)

jsm.jsexmed.org

Phillips, Elizabeth A.; Rajender, Archana; Douglas, Thomas; Brandon, Ashley F.; Munarriz, Ricardo (2015-07-01). "Sex Offenders Seeking Treatment for Sexual Dysfunction—Ethics, Medicine, and the Law". The Journal of Sexual Medicine. 12 (7): 1591–1600. doi:10.1111/jsm.12920. ISSN 1743-6095. PMC 6962056. PMID 26060942.

medicines.org.uk (Global: 4,892^nd place; English: 3,451^st place)

"Androcur 50 mg Tablets - Summary of Product Characteristics (SmPC) - (emc)". www.medicines.org.uk. 2020-05-26. Retrieved 2021-03-28.

nih.gov (Global: 5^th place; English: 5^th place)

pubmed.ncbi.nlm.nih.gov

Stahl, Stephen M. (2015-02-09). "Mechanism of action of flibanserin, a multifunctional serotonin agonist and antagonist (MSAA), in hypoactive sexual desire disorder". CNS Spectrums. 20 (1): 1–6. doi:10.1017/S1092852914000832. ISSN 1092-8529. PMID 25659981.
Mayer, Danielle; Lynch, Sarah E. (2020-07-01). "Bremelanotide: New Drug Approved for Treating Hypoactive Sexual Desire Disorder". Annals of Pharmacotherapy. 54 (7): 684–690. doi:10.1177/1060028019899152. ISSN 1060-0280. PMID 31893927. S2CID 209539372.
DeRogatis, Leonard; Rosen, Raymond C.; Goldstein, Irwin; Werneburg, Brian; Kempthorne-Rawson, Joan; Sand, Michael (March 2012). "Characterization of Hypoactive Sexual Desire Disorder (HSDD) in Men". The Journal of Sexual Medicine. 9 (3): 812–820. doi:10.1111/j.1743-6109.2011.02592.x. PMID 22239825.
Turner, Daniel; Briken, Peer (January 2018). "Treatment of Paraphilic Disorders in Sexual Offenders or Men With a Risk of Sexual Offending With Luteinizing Hormone-Releasing Hormone Agonists: An Updated Systematic Review". The Journal of Sexual Medicine. 15 (1): 77–93. doi:10.1016/j.jsxm.2017.11.013. ISSN 1743-6109. PMID 29289377.
Bloemers, Jos; van Rooij, Kim; Poels, Saskia; Goldstein, Irwin; Everaerd, Walter; Koppeschaar, Hans; Chivers, Meredith; Gerritsen, Jeroen; van Ham, Diana; Olivier, Berend; Tuiten, Adriaan (March 2013). "Toward Personalized Sexual Medicine (Part 1): Integrating the "Dual Control Model" into Differential Drug Treatments for Hypoactive Sexual Desire Disorder and Female Sexual Arousal Disorder". The Journal of Sexual Medicine. 10 (3): 791–809. doi:10.1111/j.1743-6109.2012.02984.x. PMID 23130782.
Tuiten, Adriaan; van Rooij, Kim; Bloemers, Jos; Eisenegger, Christoph; van Honk, Jack; Kessels, Rob; Kingsberg, Sheryl; Derogatis, Leonard R.; de Leede, Leo; Gerritsen, Jeroen; Koppeschaar, Hans P.F. (February 2018). "Efficacy and Safety of On-Demand Use of 2 Treatments Designed for Different Etiologies of Female Sexual Interest/Arousal Disorder: 3 Randomized Clinical Trials". The Journal of Sexual Medicine. 15 (2): 201–216. doi:10.1016/j.jsxm.2017.11.226. hdl:11370/759c7d86-e8d6-4629-8f60-3b6eea650d5f. PMID 29289554.
Tuiten, Adriaan; Michiels, Frits; Böcker, Koen BE; Höhle, Daniël; van Honk, Jack; de Lange, Robert PJ; van Rooij, Kim; Kessels, Rob; Bloemers, Jos; Gerritsen, Jeroen; Janssen, Paddy (2018-01-01). "Genotype scores predict drug efficacy in subtypes of female sexual interest/arousal disorder: A double-blind, randomized, placebo-controlled cross-over trial". Women's Health. 14: 174550651878897. doi:10.1177/1745506518788970. ISSN 1745-5065. PMC 6052493. PMID 30016917.
van Rooij, Kim; Poels, Saskia; Bloemers, Jos; Goldstein, Irwin; Gerritsen, Jeroen; van Ham, Diana; van Mameren, Frederiek; Chivers, Meredith; Everaerd, Walter; Koppeschaar, Hans; Olivier, Berend (March 2013). "Toward Personalized Sexual Medicine (Part 3): Testosterone Combined with a Serotonin1A Receptor Agonist Increases Sexual Satisfaction in Women with HSDD and FSAD, and Dysfunctional Activation of Sexual Inhibitory Mechanisms". The Journal of Sexual Medicine. 10 (3): 824–837. doi:10.1111/j.1743-6109.2012.02982.x. PMID 23130675.
Aftab, Awais; Chen, Cheryl; McBride, Jacob (April 2017). "Flibanserin and its discontents". Archives of Women's Mental Health. 20 (2): 243–247. doi:10.1007/s00737-016-0693-6. ISSN 1434-1816. PMID 27858170. S2CID 4534394.
Phillips, Elizabeth A.; Rajender, Archana; Douglas, Thomas; Brandon, Ashley F.; Munarriz, Ricardo (2015-07-01). "Sex Offenders Seeking Treatment for Sexual Dysfunction—Ethics, Medicine, and the Law". The Journal of Sexual Medicine. 12 (7): 1591–1600. doi:10.1111/jsm.12920. ISSN 1743-6095. PMC 6962056. PMID 26060942.
Vallejos, Ximena; Wu, Christine (2017-04-01). "Flibanserin: A Novel, Nonhormonal Agent for the Treatment of Hypoactive Sexual Desire Disorder in Premenopausal Women". Journal of Pharmacy Practice. 30 (2): 256–260. doi:10.1177/0897190016630409. ISSN 0897-1900. PMID 26873507. S2CID 196435523.
Thompson, Cheryl A. (2015-10-01). "Onsite pharmacist program in medical homes declared a success". American Journal of Health-System Pharmacy. 72 (19): 1596–1597. doi:10.2146/news150064. ISSN 1079-2082. PMID 26386093.
Pfaus, James G. (2015-10-22). "Treatment for Hypoactive Sexual Desire". Cell. 163 (3): 533. doi:10.1016/j.cell.2015.10.015. PMID 26496594.
Shapiro, Desiree; Stevens, Deanna; Stahl, Stephen M. (2017-10-02). "Flibanserin – the female Viagra?". International Journal of Psychiatry in Clinical Practice. 21 (4): 259–265. doi:10.1080/13651501.2017.1315138. ISSN 1365-1501. PMID 28434386. S2CID 40960102.
Puppo, Giulia; Puppo, Vincenzo (2016-02-24). "US Food and Drug Administration Approval of Addyi (Flibanserin) for Treatment of Hypoactive Sexual Desire Disorder". European Urology. 69 (2): 379–380. doi:10.1016/j.eururo.2015.09.050. PMID 26455357.
Jaspers, Loes; Feys, Frederik; Bramer, Wichor M.; Franco, Oscar H.; Leusink, Peter; Laan, Ellen T. M. (2016-04-01). "Efficacy and Safety of Flibanserin for the Treatment of Hypoactive Sexual Desire Disorder in Women: A Systematic Review and Meta-analysis". JAMA Internal Medicine. 176 (4): 453–462. doi:10.1001/jamainternmed.2015.8565. ISSN 2168-6106. PMID 26927498.
Joffe, Hylton V.; Chang, Christina; Sewell, Catherine; Easley, Olivia; Nguyen, Christine; Dunn, Somya; Lehrfeld, Kimberly; Lee, LaiMing; Kim, Myong-Jin; Slagle, Ashley F.; Beitz, Julie (2016-01-14). "FDA Approval of Flibanserin — Treating Hypoactive Sexual Desire Disorder". New England Journal of Medicine. 374 (2): 101–104. doi:10.1056/NEJMp1513686. ISSN 0028-4793. PMID 26649985.
Brotto, Lori A. (November 2015). "Flibanserin". Archives of Sexual Behavior. 44 (8): 2103–2105. doi:10.1007/s10508-015-0643-9. ISSN 0004-0002. PMID 26503709.
Clayton, Anita H; Brown, Louise; Kim, Noel N (2020-01-02). "Evaluation of safety for flibanserin". Expert Opinion on Drug Safety. 19 (1): 1–8. doi:10.1080/14740338.2020.1707804. ISSN 1474-0338. PMID 31855607. S2CID 209427946.
English, Clayton; Muhleisen, Anne; Rey, Jose A. (April 2017). "Flibanserin (Addyi): The First FDA-Approved Treatment for Female Sexual Interest/Arousal Disorder in Premenopausal Women". P & T: A Peer-Reviewed Journal for Formulary Management. 42 (4): 237–241. ISSN 1052-1372. PMC 5358680. PMID 28381915.
Dhillon, Sohita; Keam, Susan J. (September 2019). "Bremelanotide: First Approval". Drugs. 79 (14): 1599–1606. doi:10.1007/s40265-019-01187-w. ISSN 0012-6667. PMID 31429064. S2CID 201057982.
Aschenbrenner, Diane S. (October 2019). "New Drug for Hypoactive Sexual Desire Disorder in Premenopausal Women". American Journal of Nursing. 119 (10): 21. doi:10.1097/01.NAJ.0000586140.72896.b0. ISSN 0002-936X. PMID 31567244. S2CID 203625416.
Simon, James A.; Kingsberg, Sheryl A.; Portman, David; Williams, Laura A.; Krop, Julie; Jordan, Robert; Lucas, Johna; Clayton, Anita H. (November 2019). "Long-Term Safety and Efficacy of Bremelanotide for Hypoactive Sexual Desire Disorder". Obstetrics & Gynecology. 134 (5): 909–917. doi:10.1097/AOG.0000000000003514. ISSN 0029-7844. PMC 6819023. PMID 31599847.
Mayer, Danielle; Lynch, Sarah E. (2020-07-01). "Bremelanotide: New Drug Approved for Treating Hypoactive Sexual Desire Disorder". Annals of Pharmacotherapy. 54 (7): 684–690. doi:10.1177/1060028019899152. ISSN 1060-0280. PMID 31893927. S2CID 209539372.
Huerta-Reyes, Maira; Maya-Núñez, Guadalupe; Pérez-Solis, Marco Allán; López-Muñoz, Eunice; Guillén, Nancy; Olivo-Marin, Jean-Christophe; Aguilar-Rojas, Arturo (2019-10-01). "Treatment of Breast Cancer With Gonadotropin-Releasing Hormone Analogs". Frontiers in Oncology. 9: 943. doi:10.3389/fonc.2019.00943. ISSN 2234-943X. PMC 6779786. PMID 31632902.
Meani, Davide; Solarić, Mladen; Visapää, Harri; Rosén, Rose-Marie; Janknegt, Robert; Soče, Majana (2018-02-01). "Practical differences between luteinizing hormone-releasing hormone agonists in prostate cancer: perspectives across the spectrum of care". Therapeutic Advances in Urology. 10 (2): 51–63. doi:10.1177/1756287217738985. ISSN 1756-2872. PMC 5805008. PMID 29434673.
"Gonadotropin Releasing Hormone (GnRH) Analogues", LiverTox: Clinical and Research Information on Drug-Induced Liver Injury, Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases, 2018-03-20, PMID 31643199, retrieved 2021-03-28
Frank, Samuel; Tyson, Nichole A. (December 2020). "A Clinical Approach to Catamenial Epilepsy: A Review". The Permanente Journal. 24 (5): 1–3. doi:10.7812/TPP/19.145. ISSN 1552-5775. PMC 7849269. PMID 33482944.
Marques, Pedro; Skorupskaite, Karolina; George, Jyothis T.; Anderson, Richard A. (2018-06-19), Feingold, Kenneth R.; Anawalt, Bradley; Boyce, Alison; Chrousos, George (eds.), "Physiology of GNRH and Gonadotropin Secretion", Endotext, South Dartmouth (MA): MDText.com, Inc., PMID 25905297, retrieved 2021-03-28
Malinowski, Bartosz; Wiciński, Michał; Musiała, Nikola; Osowska, Ilona; Szostak, Mateusz (2019-10-25). "Previous, Current, and Future Pharmacotherapy and Diagnosis of Prostate Cancer—A Comprehensive Review". Diagnostics. 9 (4): 161. doi:10.3390/diagnostics9040161. PMC 6963205. PMID 31731466.
Connelly, Paul J.; Clark, Anna; Touyz, Rhian M.; Delles, Christian (2020-11-05). "Transgender adults, gender-affirming hormone therapy and blood pressure: a systematic review". Journal of Hypertension. 39 (2): 223–230. doi:10.1097/hjh.0000000000002632. ISSN 0263-6352. PMC 7810409. PMID 32809982.
Jing, Elizabeth; Straw-Wilson, Kristyn (2016-07-01). "Sexual dysfunction in selective serotonin reuptake inhibitors (SSRIs) and potential solutions: A narrative literature review". Mental Health Clinician. 6 (4): 191–196. doi:10.9740/mhc.2016.07.191. ISSN 2168-9709. PMC 6007725. PMID 29955469.

ncbi.nlm.nih.gov

Tuiten, Adriaan; Michiels, Frits; Böcker, Koen BE; Höhle, Daniël; van Honk, Jack; de Lange, Robert PJ; van Rooij, Kim; Kessels, Rob; Bloemers, Jos; Gerritsen, Jeroen; Janssen, Paddy (2018-01-01). "Genotype scores predict drug efficacy in subtypes of female sexual interest/arousal disorder: A double-blind, randomized, placebo-controlled cross-over trial". Women's Health. 14: 174550651878897. doi:10.1177/1745506518788970. ISSN 1745-5065. PMC 6052493. PMID 30016917.
Phillips, Elizabeth A.; Rajender, Archana; Douglas, Thomas; Brandon, Ashley F.; Munarriz, Ricardo (2015-07-01). "Sex Offenders Seeking Treatment for Sexual Dysfunction—Ethics, Medicine, and the Law". The Journal of Sexual Medicine. 12 (7): 1591–1600. doi:10.1111/jsm.12920. ISSN 1743-6095. PMC 6962056. PMID 26060942.
English, Clayton; Muhleisen, Anne; Rey, Jose A. (April 2017). "Flibanserin (Addyi): The First FDA-Approved Treatment for Female Sexual Interest/Arousal Disorder in Premenopausal Women". P & T: A Peer-Reviewed Journal for Formulary Management. 42 (4): 237–241. ISSN 1052-1372. PMC 5358680. PMID 28381915.
Simon, James A.; Kingsberg, Sheryl A.; Portman, David; Williams, Laura A.; Krop, Julie; Jordan, Robert; Lucas, Johna; Clayton, Anita H. (November 2019). "Long-Term Safety and Efficacy of Bremelanotide for Hypoactive Sexual Desire Disorder". Obstetrics & Gynecology. 134 (5): 909–917. doi:10.1097/AOG.0000000000003514. ISSN 0029-7844. PMC 6819023. PMID 31599847.
Huerta-Reyes, Maira; Maya-Núñez, Guadalupe; Pérez-Solis, Marco Allán; López-Muñoz, Eunice; Guillén, Nancy; Olivo-Marin, Jean-Christophe; Aguilar-Rojas, Arturo (2019-10-01). "Treatment of Breast Cancer With Gonadotropin-Releasing Hormone Analogs". Frontiers in Oncology. 9: 943. doi:10.3389/fonc.2019.00943. ISSN 2234-943X. PMC 6779786. PMID 31632902.
Meani, Davide; Solarić, Mladen; Visapää, Harri; Rosén, Rose-Marie; Janknegt, Robert; Soče, Majana (2018-02-01). "Practical differences between luteinizing hormone-releasing hormone agonists in prostate cancer: perspectives across the spectrum of care". Therapeutic Advances in Urology. 10 (2): 51–63. doi:10.1177/1756287217738985. ISSN 1756-2872. PMC 5805008. PMID 29434673.
"Gonadotropin Releasing Hormone (GnRH) Analogues", LiverTox: Clinical and Research Information on Drug-Induced Liver Injury, Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases, 2018-03-20, PMID 31643199, retrieved 2021-03-28
Frank, Samuel; Tyson, Nichole A. (December 2020). "A Clinical Approach to Catamenial Epilepsy: A Review". The Permanente Journal. 24 (5): 1–3. doi:10.7812/TPP/19.145. ISSN 1552-5775. PMC 7849269. PMID 33482944.
Marques, Pedro; Skorupskaite, Karolina; George, Jyothis T.; Anderson, Richard A. (2018-06-19), Feingold, Kenneth R.; Anawalt, Bradley; Boyce, Alison; Chrousos, George (eds.), "Physiology of GNRH and Gonadotropin Secretion", Endotext, South Dartmouth (MA): MDText.com, Inc., PMID 25905297, retrieved 2021-03-28
Malinowski, Bartosz; Wiciński, Michał; Musiała, Nikola; Osowska, Ilona; Szostak, Mateusz (2019-10-25). "Previous, Current, and Future Pharmacotherapy and Diagnosis of Prostate Cancer—A Comprehensive Review". Diagnostics. 9 (4): 161. doi:10.3390/diagnostics9040161. PMC 6963205. PMID 31731466.
Connelly, Paul J.; Clark, Anna; Touyz, Rhian M.; Delles, Christian (2020-11-05). "Transgender adults, gender-affirming hormone therapy and blood pressure: a systematic review". Journal of Hypertension. 39 (2): 223–230. doi:10.1097/hjh.0000000000002632. ISSN 0263-6352. PMC 7810409. PMID 32809982.
Jing, Elizabeth; Straw-Wilson, Kristyn (2016-07-01). "Sexual dysfunction in selective serotonin reuptake inhibitors (SSRIs) and potential solutions: A narrative literature review". Mental Health Clinician. 6 (4): 191–196. doi:10.9740/mhc.2016.07.191. ISSN 2168-9709. PMC 6007725. PMID 29955469.

oup.com (Global: 292^nd place; English: 233^rd place)

academic.oup.com

Thompson, Cheryl A. (2015-10-01). "Onsite pharmacist program in medical homes declared a success". American Journal of Health-System Pharmacy. 72 (19): 1596–1597. doi:10.2146/news150064. ISSN 1079-2082. PMID 26386093.

sagepub.com (Global: 609^th place; English: 451^st place)

journals.sagepub.com

Mayer, Danielle; Lynch, Sarah E. (2020-07-01). "Bremelanotide: New Drug Approved for Treating Hypoactive Sexual Desire Disorder". Annals of Pharmacotherapy. 54 (7): 684–690. doi:10.1177/1060028019899152. ISSN 1060-0280. PMID 31893927. S2CID 209539372.
Vallejos, Ximena; Wu, Christine (2017-04-01). "Flibanserin: A Novel, Nonhormonal Agent for the Treatment of Hypoactive Sexual Desire Disorder in Premenopausal Women". Journal of Pharmacy Practice. 30 (2): 256–260. doi:10.1177/0897190016630409. ISSN 0897-1900. PMID 26873507. S2CID 196435523.

semanticscholar.org (Global: 15^th place; English: 8^th place)

api.semanticscholar.org

Mayer, Danielle; Lynch, Sarah E. (2020-07-01). "Bremelanotide: New Drug Approved for Treating Hypoactive Sexual Desire Disorder". Annals of Pharmacotherapy. 54 (7): 684–690. doi:10.1177/1060028019899152. ISSN 1060-0280. PMID 31893927. S2CID 209539372.
Aftab, Awais; Chen, Cheryl; McBride, Jacob (April 2017). "Flibanserin and its discontents". Archives of Women's Mental Health. 20 (2): 243–247. doi:10.1007/s00737-016-0693-6. ISSN 1434-1816. PMID 27858170. S2CID 4534394.
Vallejos, Ximena; Wu, Christine (2017-04-01). "Flibanserin: A Novel, Nonhormonal Agent for the Treatment of Hypoactive Sexual Desire Disorder in Premenopausal Women". Journal of Pharmacy Practice. 30 (2): 256–260. doi:10.1177/0897190016630409. ISSN 0897-1900. PMID 26873507. S2CID 196435523.
Shapiro, Desiree; Stevens, Deanna; Stahl, Stephen M. (2017-10-02). "Flibanserin – the female Viagra?". International Journal of Psychiatry in Clinical Practice. 21 (4): 259–265. doi:10.1080/13651501.2017.1315138. ISSN 1365-1501. PMID 28434386. S2CID 40960102.
Clayton, Anita H; Brown, Louise; Kim, Noel N (2020-01-02). "Evaluation of safety for flibanserin". Expert Opinion on Drug Safety. 19 (1): 1–8. doi:10.1080/14740338.2020.1707804. ISSN 1474-0338. PMID 31855607. S2CID 209427946.
Dhillon, Sohita; Keam, Susan J. (September 2019). "Bremelanotide: First Approval". Drugs. 79 (14): 1599–1606. doi:10.1007/s40265-019-01187-w. ISSN 0012-6667. PMID 31429064. S2CID 201057982.
Aschenbrenner, Diane S. (October 2019). "New Drug for Hypoactive Sexual Desire Disorder in Premenopausal Women". American Journal of Nursing. 119 (10): 21. doi:10.1097/01.NAJ.0000586140.72896.b0. ISSN 0002-936X. PMID 31567244. S2CID 203625416.
Mayer, Danielle; Lynch, Sarah E. (2020-07-01). "Bremelanotide: New Drug Approved for Treating Hypoactive Sexual Desire Disorder". Annals of Pharmacotherapy. 54 (7): 684–690. doi:10.1177/1060028019899152. ISSN 1060-0280. PMID 31893927. S2CID 209539372.

springer.com (Global: 182^nd place; English: 172^nd place)

link.springer.com

Aftab, Awais; Chen, Cheryl; McBride, Jacob (April 2017). "Flibanserin and its discontents". Archives of Women's Mental Health. 20 (2): 243–247. doi:10.1007/s00737-016-0693-6. ISSN 1434-1816. PMID 27858170. S2CID 4534394.
Dhillon, Sohita; Keam, Susan J. (September 2019). "Bremelanotide: First Approval". Drugs. 79 (14): 1599–1606. doi:10.1007/s40265-019-01187-w. ISSN 0012-6667. PMID 31429064. S2CID 201057982.

tandfonline.com (Global: 286^th place; English: 209^th place)

Shapiro, Desiree; Stevens, Deanna; Stahl, Stephen M. (2017-10-02). "Flibanserin – the female Viagra?". International Journal of Psychiatry in Clinical Practice. 21 (4): 259–265. doi:10.1080/13651501.2017.1315138. ISSN 1365-1501. PMID 28434386. S2CID 40960102.
Clayton, Anita H; Brown, Louise; Kim, Noel N (2020-01-02). "Evaluation of safety for flibanserin". Expert Opinion on Drug Safety. 19 (1): 1–8. doi:10.1080/14740338.2020.1707804. ISSN 1474-0338. PMID 31855607. S2CID 209427946.

web.archive.org (Global: 1^st place; English: 1^st place)

The United States Food and Drug Administration, FDA (June 2019). "Vylessi" (PDF). Archived from the original (PDF) on June 22, 2019. Retrieved 15 April 2021.
The United States Food and Drug Administration, FDA (January 2012). "Synarel®" (PDF). Archived from the original (PDF) on November 6, 2015. Retrieved 2021-03-28.
The United States Food and Drug Administration, FDA (March 2012). "LUPRON DEPOT® -3 Month 11.25 mg" (PDF). Archived from the original (PDF) on January 18, 2017. Retrieved 2021-03-28.
The United States Food and Drug Administration, FDA (2008-09-13). "ZOLADEX® (goserelin acetate implant) 3.6 mg" (PDF). Archived from the original (PDF) on March 2, 2013. Retrieved 2021-03-28.
The United States Food and Drug Administration, FDA (June 2017). "TRIPTODUR (triptorelin) for extended-release injectable suspension, for intramuscular use" (PDF). Archived from the original (PDF) on October 19, 2020. Retrieved 2021-03-28.

worldcat.org (Global: 4^th place; English: 4^th place)

search.worldcat.org

Stahl, Stephen M. (2015-02-09). "Mechanism of action of flibanserin, a multifunctional serotonin agonist and antagonist (MSAA), in hypoactive sexual desire disorder". CNS Spectrums. 20 (1): 1–6. doi:10.1017/S1092852914000832. ISSN 1092-8529. PMID 25659981.
Mayer, Danielle; Lynch, Sarah E. (2020-07-01). "Bremelanotide: New Drug Approved for Treating Hypoactive Sexual Desire Disorder". Annals of Pharmacotherapy. 54 (7): 684–690. doi:10.1177/1060028019899152. ISSN 1060-0280. PMID 31893927. S2CID 209539372.
Turner, Daniel; Briken, Peer (January 2018). "Treatment of Paraphilic Disorders in Sexual Offenders or Men With a Risk of Sexual Offending With Luteinizing Hormone-Releasing Hormone Agonists: An Updated Systematic Review". The Journal of Sexual Medicine. 15 (1): 77–93. doi:10.1016/j.jsxm.2017.11.013. ISSN 1743-6109. PMID 29289377.
Tuiten, Adriaan; Michiels, Frits; Böcker, Koen BE; Höhle, Daniël; van Honk, Jack; de Lange, Robert PJ; van Rooij, Kim; Kessels, Rob; Bloemers, Jos; Gerritsen, Jeroen; Janssen, Paddy (2018-01-01). "Genotype scores predict drug efficacy in subtypes of female sexual interest/arousal disorder: A double-blind, randomized, placebo-controlled cross-over trial". Women's Health. 14: 174550651878897. doi:10.1177/1745506518788970. ISSN 1745-5065. PMC 6052493. PMID 30016917.
Aftab, Awais; Chen, Cheryl; McBride, Jacob (April 2017). "Flibanserin and its discontents". Archives of Women's Mental Health. 20 (2): 243–247. doi:10.1007/s00737-016-0693-6. ISSN 1434-1816. PMID 27858170. S2CID 4534394.
Phillips, Elizabeth A.; Rajender, Archana; Douglas, Thomas; Brandon, Ashley F.; Munarriz, Ricardo (2015-07-01). "Sex Offenders Seeking Treatment for Sexual Dysfunction—Ethics, Medicine, and the Law". The Journal of Sexual Medicine. 12 (7): 1591–1600. doi:10.1111/jsm.12920. ISSN 1743-6095. PMC 6962056. PMID 26060942.
Vallejos, Ximena; Wu, Christine (2017-04-01). "Flibanserin: A Novel, Nonhormonal Agent for the Treatment of Hypoactive Sexual Desire Disorder in Premenopausal Women". Journal of Pharmacy Practice. 30 (2): 256–260. doi:10.1177/0897190016630409. ISSN 0897-1900. PMID 26873507. S2CID 196435523.
Thompson, Cheryl A. (2015-10-01). "Onsite pharmacist program in medical homes declared a success". American Journal of Health-System Pharmacy. 72 (19): 1596–1597. doi:10.2146/news150064. ISSN 1079-2082. PMID 26386093.
Shapiro, Desiree; Stevens, Deanna; Stahl, Stephen M. (2017-10-02). "Flibanserin – the female Viagra?". International Journal of Psychiatry in Clinical Practice. 21 (4): 259–265. doi:10.1080/13651501.2017.1315138. ISSN 1365-1501. PMID 28434386. S2CID 40960102.
Jaspers, Loes; Feys, Frederik; Bramer, Wichor M.; Franco, Oscar H.; Leusink, Peter; Laan, Ellen T. M. (2016-04-01). "Efficacy and Safety of Flibanserin for the Treatment of Hypoactive Sexual Desire Disorder in Women: A Systematic Review and Meta-analysis". JAMA Internal Medicine. 176 (4): 453–462. doi:10.1001/jamainternmed.2015.8565. ISSN 2168-6106. PMID 26927498.
Joffe, Hylton V.; Chang, Christina; Sewell, Catherine; Easley, Olivia; Nguyen, Christine; Dunn, Somya; Lehrfeld, Kimberly; Lee, LaiMing; Kim, Myong-Jin; Slagle, Ashley F.; Beitz, Julie (2016-01-14). "FDA Approval of Flibanserin — Treating Hypoactive Sexual Desire Disorder". New England Journal of Medicine. 374 (2): 101–104. doi:10.1056/NEJMp1513686. ISSN 0028-4793. PMID 26649985.
Brotto, Lori A. (November 2015). "Flibanserin". Archives of Sexual Behavior. 44 (8): 2103–2105. doi:10.1007/s10508-015-0643-9. ISSN 0004-0002. PMID 26503709.
Clayton, Anita H; Brown, Louise; Kim, Noel N (2020-01-02). "Evaluation of safety for flibanserin". Expert Opinion on Drug Safety. 19 (1): 1–8. doi:10.1080/14740338.2020.1707804. ISSN 1474-0338. PMID 31855607. S2CID 209427946.
English, Clayton; Muhleisen, Anne; Rey, Jose A. (April 2017). "Flibanserin (Addyi): The First FDA-Approved Treatment for Female Sexual Interest/Arousal Disorder in Premenopausal Women". P & T: A Peer-Reviewed Journal for Formulary Management. 42 (4): 237–241. ISSN 1052-1372. PMC 5358680. PMID 28381915.
Dhillon, Sohita; Keam, Susan J. (September 2019). "Bremelanotide: First Approval". Drugs. 79 (14): 1599–1606. doi:10.1007/s40265-019-01187-w. ISSN 0012-6667. PMID 31429064. S2CID 201057982.
Aschenbrenner, Diane S. (October 2019). "New Drug for Hypoactive Sexual Desire Disorder in Premenopausal Women". American Journal of Nursing. 119 (10): 21. doi:10.1097/01.NAJ.0000586140.72896.b0. ISSN 0002-936X. PMID 31567244. S2CID 203625416.
Simon, James A.; Kingsberg, Sheryl A.; Portman, David; Williams, Laura A.; Krop, Julie; Jordan, Robert; Lucas, Johna; Clayton, Anita H. (November 2019). "Long-Term Safety and Efficacy of Bremelanotide for Hypoactive Sexual Desire Disorder". Obstetrics & Gynecology. 134 (5): 909–917. doi:10.1097/AOG.0000000000003514. ISSN 0029-7844. PMC 6819023. PMID 31599847.
Mayer, Danielle; Lynch, Sarah E. (2020-07-01). "Bremelanotide: New Drug Approved for Treating Hypoactive Sexual Desire Disorder". Annals of Pharmacotherapy. 54 (7): 684–690. doi:10.1177/1060028019899152. ISSN 1060-0280. PMID 31893927. S2CID 209539372.
Huerta-Reyes, Maira; Maya-Núñez, Guadalupe; Pérez-Solis, Marco Allán; López-Muñoz, Eunice; Guillén, Nancy; Olivo-Marin, Jean-Christophe; Aguilar-Rojas, Arturo (2019-10-01). "Treatment of Breast Cancer With Gonadotropin-Releasing Hormone Analogs". Frontiers in Oncology. 9: 943. doi:10.3389/fonc.2019.00943. ISSN 2234-943X. PMC 6779786. PMID 31632902.
Henry., Kronenberg (2016). Williams Textbook of Endocrinology (Thirteenth ed.). Elsevier. ISBN 978-0-323-29738-7. OCLC 1229753362.
Meani, Davide; Solarić, Mladen; Visapää, Harri; Rosén, Rose-Marie; Janknegt, Robert; Soče, Majana (2018-02-01). "Practical differences between luteinizing hormone-releasing hormone agonists in prostate cancer: perspectives across the spectrum of care". Therapeutic Advances in Urology. 10 (2): 51–63. doi:10.1177/1756287217738985. ISSN 1756-2872. PMC 5805008. PMID 29434673.
Frank, Samuel; Tyson, Nichole A. (December 2020). "A Clinical Approach to Catamenial Epilepsy: A Review". The Permanente Journal. 24 (5): 1–3. doi:10.7812/TPP/19.145. ISSN 1552-5775. PMC 7849269. PMID 33482944.
Gargiulo., Jerome F. Strauss, Robert L. Barbieri and Antonio R. (2019). Yen and Jaffe's Reproductive Endocrinology (Eighth ed.). OCLC 1237734908.{{cite book}}: CS1 maint: multiple names: authors list (link)
Connelly, Paul J.; Clark, Anna; Touyz, Rhian M.; Delles, Christian (2020-11-05). "Transgender adults, gender-affirming hormone therapy and blood pressure: a systematic review". Journal of Hypertension. 39 (2): 223–230. doi:10.1097/hjh.0000000000002632. ISSN 0263-6352. PMC 7810409. PMID 32809982.
Jing, Elizabeth; Straw-Wilson, Kristyn (2016-07-01). "Sexual dysfunction in selective serotonin reuptake inhibitors (SSRIs) and potential solutions: A narrative literature review". Mental Health Clinician. 6 (4): 191–196. doi:10.9740/mhc.2016.07.191. ISSN 2168-9709. PMC 6007725. PMID 29955469.

worldcat.org

Henry., Kronenberg (2016). Williams Textbook of Endocrinology (Thirteenth ed.). Elsevier. ISBN 978-0-323-29738-7. OCLC 1229753362.
Gargiulo., Jerome F. Strauss, Robert L. Barbieri and Antonio R. (2019). Yen and Jaffe's Reproductive Endocrinology (Eighth ed.). OCLC 1237734908.{{cite book}}: CS1 maint: multiple names: authors list (link)

Drugs and sexual desire (English Wikipedia)

doi.org (Global: 2nd place; English: 2nd place)